Thus, in prostate cancer, induction of aromatase via ArPII in prostate epithelia results in estrogen synthesis that, in turn, affects the prostate epithelia in an autocrine/intracrine fashion via binding to ER-α. This evidence concerns the gene CYP19A1 and Familial prostate cancer.